The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lulu,Wang

第一单位： Oncology Department, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Shapingba District, Chongqing, China.

作者： Lulu,Wang ^[1] ; Yan,Li ^[1] ; Luchun,Li ^[1] ; Zhijuan,Wu ^[1] ; Dan,Yang ^[1] ; Huiwen,Ma ^[1] ; Donglin,Wang ^[1]

作者单位： Oncology Department, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Shapingba District, Chongqing, China. ^[1]

关键词 EGFR-TKI chemotherapy first-line treatment icotinib non-small-cell lung cancer

DOI 10.2147/OTT.S157755

PMID 29731642

发布时间 2023-11-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

OncoTargets and therapy

2018年11卷

2345-2353页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis.

OncoTargets and therapy

相似文献

OncoTargets and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The effect of icotinib combined with chemotherapy in untreated non-small-cell lung cancer that harbored EGFR-sensitive mutations in a real-life setting: a retrospective analysis.

OncoTargets and therapy

相似文献

OncoTargets and therapy

相关期刊

检索历史清除